[1] Einhorn D, Reaven G M, Cobin R H, et al. American college of endocrinology position statement on the insulin resistance syndrome[J]. Endocr Pract, 2003, 9(3): 237-252.
[2] 邢小燕, 杨文英, 杨兆军. 胰岛素抵抗指数在不同糖耐量人群中诊断代谢综合征的作用[J]. 中华糖尿病杂志, 2004, 12(3): 182-186.
[3] 中华医学会糖尿病学分会胰岛素抵抗学组(筹). 胰岛素抵抗评估方法和应用的专家指导意见[J]. 中华糖尿病杂志, 2018, 10(6): 377-385.
[4] James D E, Stöckli J, Birnbaum M J. The aetiology and molecular landscape of insulin resistance[J]. Nat Rev Mol Cell Biol, 2021, 22(11): 751-771.
[5] Lee S H, Park S Y, Choi C S. Insulin resistance: from mechanisms to therapeutic strategies[J]. Diabetes Metab J, 2022, 46(1): 15-37.
[6] Chen J Q, Wu K X, Cao W C, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and multi-vessel coronary artery disease: a cross-sectional study[J]. Lipids Health Dis, 2023, 22(1): 121.
[7] Jiang M, Yang J M, Zou H Y A, et al. Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States[J]. Lipids Health Dis, 2022, 21(1): 30.
[8] Usta A, Avci E, Bulbul C B, et al. The monocyte counts to HDL cholesterol ratio in obese and lean patients with polycystic ovary syndrome[J]. Reprod Biol Endocrinol, 2018, 16(1): 34.
[9] Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7): 539-553.
[10] Matthews D R, Hosker J P, Rudenski A S, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7): 412-419.
[11] 苏青, 臧丽. 胰岛素抵抗的历史、机制和管理[J]. 中华糖尿病杂志, 2023, 15(1): 6-13.
[12] Ren Z, Luo S, Liu L. The positive association between white blood cell count and metabolic syndrome is Independent of insulin resistance among a Chinese population: a cross-sectional study[J]. Front Immunol, 2023, 14: 1104180.
[13] Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes[J]. Immunity, 2018, 49(4): 595-613.
[14] Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state[J]. Circulation, 2004, 110(12): 1564-1571.
[15] Akash M S H, Rehman K, Liaqat A. Tumor necrosis Factor-Alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J]. J Cell Biochem, 2018, 119(1): 105-110.
[16] Akbari M, Hassan-Zadeh V. IL-6 signalling pathways and the development of type 2 diabetes[J]. Inflammopharmacology, 2018, 26(3): 685-698.
[17] Takaeko Y, Matsui S, Kajikawa M, et al. Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men[J]. J Clin Lipidol, 2019, 13(4): 664-672.e1.
[18] Ganjali S, Gotto A M J, Ruscica M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J]. J Cell Physiol, 2018, 233(12): 9237-9246.
[19] Huang H, Wang Q, Shi X, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a cross-sectional study[J]. Mediators Inflamm, 2021, 9: 6642246.
[20] Wang W, Chen Z Y, Guo X L, et al. Monocyte to High-Density lipoprotein and apolipoprotein a1 ratios: novel indicators for metabolic syndrome in Chinese newly diagnosed type 2 diabetes[J]. Front Endocrinol, 2022, 13: 935776.
[21] Donath M Y. Targeting inflammation in the treatment of type 2 diabetes: time to start[J]. Nat Rev Drug Discov, 2014, 13(6): 465-476.
[22] Saltiel A R, Olefsky J M. Inflammatory mechanisms linking obesity and metabolic disease[J]. J Clin Invest, 2017, 127(1): 1-4.
[23] Rohm T V, Meier D T, Olefsky J M, et al. Inflammation in obesity, diabetes, and related disorders[J]. Immunity, 2022, 55(1): 31-55.
[24] Suren Garg S, Kushwaha K, Dubey R, et al. Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions[J]. Diabetes Res Clin Pract, 2023, 200: 110691.
[25] Esteghamati A, Khalilzadeh O, Anvari M, et al. Metabolic syndrome and insulin resistance significantly correlate with body mass index[J]. Arch Med Res, 2008, 39(8): 803-808.
[26] Martinez K E, Tucker L A, Bailey B W, et al. Expanded normal weight obesity and insulin resistance in US adults of the national health and nutrition examination survey[J]. J Diabetes Res, 2017, 2017: 9502643.
|